Cite
HARVARD Citation
Cheng, X. et al. (2019). Efficacy and safety of eltrombopag in the treatment of severe chronic immune thrombocytopenia in children of China: A single-center observational study. International journal of immunopathology and pharmacology. p. . [Online].